BP’s Celgene Corp CELG Stock Holding History

BP’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-112,000	Closed	-$11.1M	–	555
2019 Q3	$11.1M	Buy	112,000 +36,000	+47%	+$3.42M	0.41%	54
2019 Q2	$7.03M	Hold	76,000	–	–	0.26%	93
2019 Q1	$7.17M	Hold	76,000	–	–	0.28%	97
2018 Q4	$4.88M	Sell	76,000 -49,000	-39%	-$3.62M	0.2%	125
2018 Q3	$11.2M	Buy	125,000 +15,000	+14%	+$1.33M	0.34%	77
2018 Q2	$8.73M	Buy	110,000 +20,400	+23%	+$1.69M	0.28%	86
2018 Q1	$7.99M	Hold	89,600	–	–	0.29%	92
2017 Q4	$9.35M	Sell	89,600 -22,400	-20%	-$2.53M	0.33%	77
2017 Q3	$16.3M	Hold	112,000	–	–	0.58%	43
2017 Q2	$14.5M	Sell	112,000 -7,000	-6%	-$858K	0.53%	46
2017 Q1	$14.8M	Buy	119,000 +22,000	+23%	+$2.63M	0.56%	42
2016 Q4	$11.2M	Hold	97,000	–	–	0.42%	58
2016 Q3	$10.1M	Buy	97,000 +47,000	+94%	+$5.09M	0.39%	72
2016 Q2	$4.93M	Hold	50,000	–	–	0.2%	149
2016 Q1	$5M	Sell	50,000 -10,000	-17%	-$1.03M	0.2%	146
2015 Q4	$7.19M	Sell	60,000 -20,000	-25%	-$2.31M	0.29%	105
2015 Q3	$8.64M	Sell	80,000 -20,000	-20%	-$2.48M	0.39%	85
2015 Q2	$11.6M	Sell	100,000 -20,000	-17%	-$2.29M	0.43%	72
2015 Q1	$13.8M	Sell	120,000 -6,000	-5%	-$717K	0.44%	64
2014 Q4	$14.1M	Buy	126,000 +24,000	+24%	+$2.53M	0.36%	70
2014 Q3	$9.67M	Buy	102,000 +72,000	+240%	+$6.5M	0.28%	94
2014 Q2	$2.58M	Hold	30,000	–	–	0.08%	214
2014 Q1	$2.09M	Sell	30,000 -20,000	-40%	-$1.58M	0.07%	235
2013 Q4	$4.22M	Buy	+50,000	New	+$3.96M	0.15%	146

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

BP's CELG Position: Q4 2019 in Review

BP sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 112,000 shares — an estimated $11.1M sold.

BP first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $16.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

BP reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
BP sold 112,000 Celgene Corp shares in Q4 2019, an estimated $11.1M.
BP first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
BP's Celgene Corp position peaked at $16.3M in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on BP's 13F filing for Q4 2019, filed 7 Feb 2020.